Page last updated: 2024-11-08

pilocarpine and Methemoglobinemia

pilocarpine has been researched along with Methemoglobinemia in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karashima, D1
Takahashi, S1
Shigematsu, A1

Other Studies

1 other study available for pilocarpine and Methemoglobinemia

ArticleYear
[Induction of hepatic microsomal drug metabolizing enzymes and methemoglobinemia induced by local anesthetics].
    Masui. The Japanese journal of anesthesiology, 1973, Volume: 22, Issue:11

    Topics: Anesthetics, Local; Animals; Cats; Cytochrome P-450 Enzyme System; Enzyme Induction; Methemoglobinem

1973